This study is testing a new device called ProBot, which uses a robot and a special ultrasound probe to perform prostate biopsies. The goal is to see if this new method is safe and works well for diagnosing prostate cancer. You might be able to join if you are a man between 40 and 75 years old and have certain "high risk" features, such as a high PSA (prostate-specific antigen) level or an abnormal digital rectal exam (DRE). Researchers will look at how much discomfort or pain you experience during the procedure and if there are any complications. This study is a Phase 1 trial, meaning it's an early step to check the device's safety and how practical it is to use.

Study design

This is an interventional study, which means participants will receive the ProBot prostate biopsy. It plans to enroll 60 men.

What's involved

You would undergo a prostate biopsy using the ProBot device. Complications will be recorded for up to one month after the procedure.

Compensation

Not stated in the trial record.

Follow-up

Complications will be monitored for up to one month after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.